CPH Pharma ApS: Financial statements 2018
CVR: 37110248
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
CPH Pharma ApS (CVR 37110248) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK -103,613 and a net result of DKK -419,887 compared with DKK -196,109 the year before. Equity in the 2018 report amounted to DKK -607,258. The company had 1 employee in the financial year.
- Gross Profit
- DKK -103,613
- Profit/Loss
- DKK -419,887
- Equity
- DKK -607,258
- Total Assets
- DKK 39
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | -104 t. | -420 t. | -607 t. | 1 |
| 2017 | - | 80 t. | -196 t. | -187 t. | - |
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
As of July 1, 2018, Qi Holding APS is registered as an owner of CPH Pharma ApS with an ownership share of 100%.
CPH Pharma ApS has published its annual report for 2017. Gross profit came to DKK 80,057, and the net result was DKK -196,109.
About CPH Pharma ApS
CPH Pharma ApS is a Danish company of the type Anpartsselskab based in Værløse, founded in 2015. The company is registered under the industry Rådgivende ingeniøraktiviteter inden for produktions- og maskinteknik. The management consists of Kamran Khasadar. The company is owned by Qi Holding APS. The company has 0 employees (2018). In 2025, the company reported a gross profit of DKK 4,432,157 and a net result of DKK 1,881,849 compared with DKK 1,257,143 the year before. Equity in the 2025 report amounted to DKK 3,102,300.